Amy E. Noser

Amy E. Noser

Auto-generated profile, based on publicly available information

Amy E. Noser

Department of Family Medicine and Community Health, University of Minnesota Medical School , Minneapolis, MN

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Health Psychology
Verified
Journal Article
Open access
ANAmy E. Noser
Amy E. Noser
HDHongying Dai
Hongying Dai
AMArwen M. Marker
Arwen M. Marker
JRJennifer Raymond
Jennifer Raymond
SMShideh Majidi
Shideh Majidi
SPSusana R. Patton
Susana R. Patton
To examine trajectories of two types of type 1 diabetes (T1D) specific distress (i.e., daily T1D management and worries about the future and long-term complications) and the moderating role of parental depression in parents of children newly diagnosed with T1D. A total of 126 families of 5- to 9-year-olds with new-onset T1D enrolled in the study. One-hundred twenty-five families completed study measures at baseline, 102 at 6-month follow-up, and 89 at 12-month follow-up. Parents completed measures of depression and T1D-specific distress concerning daily T1D management and worries about the future and long-term complications at baseline and at 6- and 12-month follow-ups. We used multilevel modeling to examine 12-month trajectories of daily and long-term T1D-specific distress and to examine if parental depression modified these trajectories. Results showed a significant reduction in daily T1D-specific distress from baseline to 6-month follow-up and maintenance of daily T1D-specific distress from 6- to 12-month follow-up. The significant interaction of baseline parental depression and time indicated that parents with depressive symptoms had a smaller reduction in daily T1D-specific distress from baseline to 6-month follow-up compared to parents without depressive symptoms. Findings for long-term T1D-specific distress indicated that parents with depressive symptoms reported higher distress across all assessment points, with peak long-term T1D-specific distress for parents with depressive symptoms occurring at 6-month follow-up. Many parents experienced significant T1D-specific distress for a period of time following their child's initial diagnosis and this distress appears to be exacerbated by parental depressive symptoms. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

26 October 2022 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
ANAmy E. Noser
Amy E. Noser
RGRobert C. Gibler
Robert C. Gibler
RRRachelle R. Ramsey
Rachelle R. Ramsey
RWRebecca E. Wells
Rebecca E. Wells
ESElizabeth K. Seng
Elizabeth K. Seng
KHKevin A. Hommel
Kevin A. Hommel

4 June 2020 in Clinical Psychology: Science and Practice
Verified
Journal Article
Closed access
PDF file
CBCassandra L. Boness
Cassandra L. Boness
RHRachel Hershenberg
Rachel Hershenberg
JKJoanna Kaye
Joanna Kaye
MMMargaret‐Anne Mackintosh
Margaret‐Anne Mackintosh
DGDamion J. Grasso
Damion J. Grasso
SRSusan D. Raffa
Susan D. Raffa
The American Psychological Association's Society of Clinical Psychology recently adopted the “Tolin Criteria” to evaluate empirically supported treatments. These criteria better account for the strength and quality ofrapidly accumulating evidence bases for various treatments. Here, we apply this framework to cognitive behavioral therapy for insomnia (CBT‐I). Following procedures outlined by Tolin, McKay, et al. (2015), Step 1 included an examination of quantitative systematic reviews; nine met inclusion criteria. Step 2 evaluated review quality and effect size data. We found high‐quality evidence that CBT‐I produces clinically and statistically significant effects on insomnia and other sleep‐related outcomes. Based on the Tolin Criteria, the literature merits a “strong” recommendation for CBT‐I. This report is a working model for subsequent applications of the Tolin Criteria.

4 July 2017 in Journal of Pediatric Psychology
Verified
Journal Article
Open access
PDF file
JAJason Van Allen
Jason Van Allen
ANAmy E Noser
Amy E Noser
ALAndrew K Littlefield
Andrew K Littlefield
PSPaige L Seegan
Paige L Seegan
MCMark Clements
Mark Clements
SPSusana R. Patton
Susana R. Patton
The Self-Efficacy for Diabetes Scale (SED) is a widely used measure of diabetes-specific self-efficacy with three subscales: diabetes-specific self-efficacy (SED-D), medical self-efficacy (SED-M), and general self-efficacy (SED-G). The present study examined the factor structure and construct validity of the SED in 116 youth, aged 10–16 years (13.60 ± 1.87), with type 1 diabetes mellitus. Confirmatory factor analysis (CFA) was used to examine the factor structure of the SED. Correlational and regression analyses examined relations between subscales and select outcomes. CFA of the original three-factor structure provided a poor fit to the data. Factor models using rescaled items were tested. Results provided preliminary evidence for the SED-D as an independent one-factor model, and for a reduced one-factor model. Significant associations were found between the SED subscales, responsibility for diabetes management, and glycated hemoglobin. Results provide limited support for the SED-D as a reliable and valid measure of diabetes-specific self-efficacy.

29 May 2020 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
AMAndrew McConville
Andrew McConville
ANAmy E. Noser
Amy E. Noser
ENEve‐Lynn Nelson
Eve‐Lynn Nelson
MCMark A. Clements
Mark A. Clements
SMShideh Majidi
Shideh Majidi
SPSusana R. Patton
Susana R. Patton

16 July 2018 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
ANAmy E. Noser
Amy E. Noser
SMShideh Majidi
Shideh Majidi
JFJonathan Finch
Jonathan Finch
MCMark A. Clements
Mark A. Clements
EYErin M. Youngkin
Erin M. Youngkin
SPSusana R. Patton
Susana R. Patton